Elevance Health, Inc. $ELV Shares Sold by TD Waterhouse Canada Inc.

Key Points

• TD Waterhouse Canada Inc. reduced its Elevance Health stake by 24.6% in the third quarter, selling 5,565 shares and retaining 17,033 shares valued at approximately $6.5 million.
• Institutional investors and hedge funds own 89.24% of Elevance Health’s stock, with several firms recently increasing their positions.
• Elevance shares opened at $430.06, near their 52-week high, while analysts maintain a “Moderate Buy” consensus and an average price target of $441.71.

TD Waterhouse Canada Inc. decreased its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 24.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 17,033 shares of the company's stock after selling 5,565 shares during the period. TD Waterhouse Canada Inc.'s holdings in Elevance Health were worth $6,504,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ELV. Field & Main Bank boosted its holdings in shares of Elevance Health by 1.3% during the second quarter. Field & Main Bank now owns 1,883 shares of the company's stock worth $728,000 after purchasing an additional 25 shares during the last quarter. Tranquilli Financial Advisor LLC grew its position in shares of Elevance Health by 1.3% in the second quarter. Tranquilli Financial Advisor LLC now owns 2,081 shares of the company's stock valued at $805,000 after purchasing an additional 26 shares during the period. Mather Group LLC. grew its position in shares of Elevance Health by 3.5% in the third quarter. Mather Group LLC. now owns 766 shares of the company's stock valued at $298,000 after purchasing an additional 26 shares during the period. WealthCollab LLC increased its stake in Elevance Health by 42.2% in the first quarter. WealthCollab LLC now owns 91 shares of the company's stock valued at $27,000 after purchasing an additional 27 shares during the last quarter. Finally, Signet Financial Management LLC increased its stake in Elevance Health by 3.5% in the first quarter. Signet Financial Management LLC now owns 837 shares of the company's stock valued at $245,000 after purchasing an additional 28 shares during the last quarter. Institutional investors and hedge funds own 89.24% of the company's stock.

Elevance Health Price Performance

Shares of NYSE ELV opened at $430.06 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.52 and a quick ratio of 1.52. Elevance Health, Inc. has a 1-year low of $274.84 and a 1-year high of $436.24. The company has a market capitalization of $93.27 billion, a price-to-earnings ratio of 14.57, a PEG ratio of 2.23 and a beta of 0.70. The business has a 50-day moving average of $404.84 and a 200-day moving average of $387.58.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Robert W. Baird increased their target price on Elevance Health from $331.00 to $393.00 and gave the stock a "neutral" rating in a research report on Thursday, July 16th. Barclays lifted their price target on Elevance Health from $457.00 to $469.00 and gave the company an "overweight" rating in a report on Wednesday, October 7th. Raymond James Financial set a $450.00 price target on Elevance Health in a report on Tuesday, July 7th. Royal Bank Of Canada dropped their price objective on shares of Elevance Health from $439.00 to $424.00 and set a "sector perform" rating for the company in a research note on Thursday, July 16th. Finally, Truist Financial increased their price objective on shares of Elevance Health from $450.00 to $475.00 and gave the stock a "buy" rating in a report on Tuesday, July 14th. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, Elevance Health has an average rating of "Moderate Buy" and a consensus target price of $441.71.

Elevance Health Company Profile

Elevance Health, Inc NYSE: ELV is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.